CJC-1295 no DAC: 0.1mg Ipamorelin: 0.15mg BPC-157: 0.25mg GHK-Cu: 1mg CJC-1295 no DAC: 0.1mg Ipamorelin: 0.15mg BPC-157: 0.25mg (optional second dose) TB-500: 2.5mg during loading, 2mg maintenance Tirzepatide: Per prescribed escalation schedule This protocol requires significant commitment to injection frequency but addresses all major concerns simultaneously
Both KD and MCT-KD increase beneficial bacteria such as Akkermansia , Lactobacillus , Blautia , and Romboutsia , while reducing pro-inflammatory species including Desulfovibrio and Turicibacter [35, 146]
10.1016/j.lfs.2021.119990 83 RezaeianL.Kalalian-MoghaddamH.MohseniF.KhaksariM.RafaieeR
[Google Scholar] 59.Kadir RE, Omotoso GO, Balogun TJ, Oyewopo AO
In many cases, patients will begin to notice a decrease in pain or inflammation within a few days to a week after their first injection